Hepatocellular Carcinoma Treatment, Survival Varies Among VA Regions

Veterans have higher rates of cirrhosis, hepatitis C infection, obesity, high alcohol use and diabetes—all of which put them at greater risk of hepatocellular carcinoma. Treatment is challenging, and a new study found that it tends to be inconsistent across regions within VA healthcare, with the West providing more interventions and having longer survival.

Advanced Liver Fibrosis Increases Risk of HCC Diagnosis

While it is well-understood that both nonalcoholic fatty liver disease (NAFLD) and hepatitis C virus (HCV) infection commonly result in hepatic fibrosis and might lead to cirrhosis, it has not been clear whether advanced fibrosis, determined by measurements of liver stiffness, increases the incidence of hepatocellular carcinoma in veterans.

Why Diabetes Patients With NAFLD Have Higher HCC Risk

While it is recognized that patients with nonalcoholic fatty liver disease who also have Type 2 diabetes mellitus (DM) have a high risk of progression to hepatocellular carcinoma. Exactly what causes the higher risks remain unclear, however, according to a new study.

Surveillance, Barriers to Care Key to Federal Medicine Fight Against HCC

Mortality rates from most cancers have declined in recent years, but deaths from hepatocellular carcinoma continue to climb. Both the VA and the DoD are moving aggressively to detect and treat liver disease before it progresses to hepatocellular carcinoma (HCC) and to quickly identify patients who have developed this devastating disease.